Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study

Wyles D, Bräu N, Kottilil S, Daar ES, Ruane P, Workowski K, et al.. Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2017;65(1):6-12.

Publication Type:

Journal Article

Source:

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, Volume 65, Issue 1, p.6-12 (2017)

Keywords:

ASTRAL 5, HCV-HIV coinfection, hepatitis C virus, sofosbuvir, velpatasvir
Top